Two companies – Biontech, RNA vaccine and Neon Therapeutics, peptide vaccine – reported very positive results of neo-antigen vaccines in patients with refractory metastatic melanoma. Continue reading
Tag Archives: T-helper
Immune Design files IPO for immuno-oncology CTL and T-helper platforms
Immune Design is the latest immuno-oncology company to file an Initial Public Offering to raise money to advance its platform technology and products. The company has 2 principal approaches to direct the immune system to fight cancer… Continue reading